Physician profile
Christopher M Kidd
NPI 1316218431
$60,182.46
in general payments reported to CMS, 2019-2025
9 companies · $56K in 2025
The $56K reported for 2025 was more than what 91% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,525 · 2020: $288 · 2021: $265 · 2023: $84.93 · 2024: $273 · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $46K · Travel and Lodging: $8,484 · Food and Beverage: $1,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,793.75 |
| Travel and Lodging | $8,484.33 |
| Food and Beverage | $1,826.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $55,879.33 | 2024-2025 | |
| Arthrex, INC. | $3,123.32 | 2019 | |
| Stryker Corporation | $403.52 | 2020-2023 | Gravity Synchfix |
| Micromed INC | $276.15 | 2019 | |
| Depuy Synthes Sales INC. | $250.53 | 2019-2024 | Na, Dynacord, Truespan Orthocord |
| Ferring Pharmaceuticals INC. | $112.20 | 2019 | |
| Novastep INC. | $86.71 | 2021 | |
| Pacira Therapeutics, INC. | $29.98 | 2021 | |
| Saxum Surgical, INC. | $20.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kidd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.